Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster-Reference-Cited by-同舟云学术

Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster

Published:2021-01-01 Issue:1 Volume:10 Page:797-809
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Brustolin Marco¹^ORCID,Rodon Jordi¹^ORCID,Rodríguez de la Concepción María Luisa²,Ávila-Nieto Carlos²,Cantero Guillermo¹,Pérez Mónica¹,Te Nigeer¹,Noguera-Julián Marc²³,Guallar Víctor⁴⁵,Valencia Alfonso⁴⁵,Roca Núria¹,Izquierdo-Useros Nuria²⁶,Blanco Julià²³⁶,Clotet Bonaventura²³⁶,Bensaid Albert¹^ORCID,Carrillo Jorge²,Vergara-Alert Júlia¹^ORCID,Segalés Joaquim⁷⁸^ORCID

Affiliation:

1. IRTA, Centre de Recerca en Sanitat Animal (CReSA, IRTA-UAB), Caldes de Montbui, Spain

2. IrsiCaixa AIDS Research Institute, Badalona, Spain

3. University of Vic-Central University of Catalonia (UVic-UCC), Catalonia, Spain

4. Barcelona Supercomputing Center (BSC), Barcelona, Spain

5. Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain

6. Germans Trias i Pujol Research Institute (IGTP), Badalona, Spain

7. UAB, Centre de Recerca en Sanitat Animal (CReSA, IRTA-UAB), Barcelona, Spain

8. Departament de Sanitat i Anatomia Animals, Facultat de Veterinària, UAB, Barcelona, Spain

Funder

Crowdfunding initiative of https://www.yomecorono.com

CBIG Consortium (constituted by IRTA-CReSA, BSC, & IrsiCaixa) supported by Grifols pharmaceutical

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2021.1913974

Reference41 articles.

1. Coronavirus Disease 2019 (COVID-19): A Brief Report

2. Human neutralizing antibodies elicited by SARS-CoV-2 infection

3. Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

4. Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans

5. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control;Signal Transduction and Targeted Therapy;2024-09-11

2. Monitoring SARS-CoV-2 infection in urban and peri-urban wildlife species from Catalonia (Spain);One Health Outlook;2024-09-01

3. Survey of severe acute respiratory syndrome coronavirus 2 in captive and free-ranging wildlife from Spain;Veterinary Research;2024-07-19

4. A human-ACE2 knock-in mouse model for SARS-CoV-2 infection recapitulates respiratory disorders but avoids neurological disease associated with the transgenic K18-hACE2 model;2024-06-12

5. Plitidepsin as an Immunomodulator against Respiratory Viral Infections;The Journal of Immunology;2024-02-28